Stockscreener 앱 받기
38.96
10.58%
-4.61
시간 외 거래:
38.20
-0.76
-1.95%
Sionna Therapeutics Inc 주식(SION)의 최신 뉴스
Sionna Therapeutics Shares Lower After RBC Downgrade - MarketScreener
Sionna Therapeutics stock tumbles after RBC downgrade By Investing.com - Investing.com Canada
SION Downgraded by RBC Capital: Today's Analyst Rating | SION Stock News - GuruFocus
RBC Downgrades Sionna Therapeutics to Underperform From Sector Perform, Keeps $24 Price Target, Speculative Risk - MarketScreener
What drives Sionna Therapeutics Inc stock priceEarnings Forecast Updates & Rapid Capital Trading - earlytimes.in
Sionna Therapeutics Insider Sold Shares Worth $4,814,205, According to a Recent SEC Filing - MarketScreener
OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $4.8m By Investing.com - Investing.com Nigeria
OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $4.8m - Investing.com India
Shareholder OrbiMed Advisors LLC Sells 108,073 ($4.8M) Of Sionna Therapeutics Inc [SION] - TradingView
Major Stock Sell-Off by Sionna Therapeutics Directors! - TipRanks
Major Stock Sale Alert: Sionna Therapeutics Shares on the Move! - TipRanks
Shareholder Orbimed Private Investments Viii Lp Files To Sell 1,047,770 Of Sionna Therapeutics Inc [SION] - TradingView
Owner RA Capital Management LP Sells 30,316 ($1.2M) Of Sionna Therapeutics Inc [SION] - TradingView
RA Capital funds report SION insider stock sales in Form 4 filing - Stock Titan
SION Crosses Above Average Analyst Target - Nasdaq
Sionna Therapeutics to Participate in Upcoming December Investor Conferences - Yahoo Finance
Owner Blackwell Partners LLC-Series A Files To Sell 7,609 Of Sionna Therapeutics Inc [SION] - TradingView
Is Sionna Therapeutics Inc. stock a smart buy before Fed meetingGap Down & High Yield Equity Trading Tips - newser.com
Will Sionna Therapeutics Inc. stock reach Wall Street targetsMarket Risk Report & Reliable Intraday Trade Alerts - newser.com
Sionna Therapeutics (NASDAQ:SION) Upgraded at BTIG Research - Defense World
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m By Investing.com - Investing.com Nigeria
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m - Investing.com
[Form 4] Sionna Therapeutics, Inc. Insider Trading Activity - Stock Titan
Owner RA Capital Management LP Sells 136,351 ($5.5M) Of Sionna Therapeutics Inc [SION] - TradingView
Sionna Therapeutics(SION.US) 10% Shareholder Sells US$5.5 Million in Common Stock - 富途牛牛
Is Sionna Therapeutics Inc. stock a safe buy before earningsTrade Risk Report & Risk Controlled Daily Plans - newser.com
Owner RA Capital Healthcare Fund LP Files To Sell 2,278 Of Sionna Therapeutics Inc [SION] - TradingView
How Sionna Therapeutics Inc. stock performs in rising dollar environmentMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
What Fibonacci levels say about Sionna Therapeutics Inc. reboundJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com
What Wall Street predicts for Sionna Therapeutics Inc. stock price2025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com
Will Sionna Therapeutics Inc. stock go up soonJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
BTIG Research Initiates Coverage on Sionna Therapeutics With Buy Rating, $50 Price Target - MarketScreener
BTIG Initiates Coverage of Sionna Therapeutics (SION) with Buy Recommendation - Nasdaq
How analysts rate Sionna Therapeutics Inc. stock todayQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential - TipRanks
Is Sionna Therapeutics Inc. stock a safe haven assetJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy - MSN
0.30%
1.75%
자본화:
|
볼륨(24시간):